Amarin Corp Plcuk (AMRN) Income towards Parent Company (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Income towards Parent Company of -$10.5 million for Q1 2026, up 33.03% YoY from -$7.9 million in Q1 2025, and down 758.82% sequentially from -$1.2 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Income towards Parent Company (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Income towards Parent Company across 17 years of filings, most recently posting -$10.5 million for Q1 2026.

  • In Q1 2026, Income towards Parent Company rose 33.03% year-over-year to -$10.5 million; the TTM figure through Mar 2026 stood at -$33.6 million (down 109.94% YoY), while the FY2025 annual figure was -$38.8 million, down 277.89% from the prior year.
  • Income towards Parent Company fell to -$10.5 million in Q1 2026, from -$1.2 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for AMRN reached as high as $110.0 million in Q4 2022 and fell as low as -$70.0 million in Q2 2022.
  • The 5-year median for Income towards Parent Company is -$10.5 million (2026), against an average of -$6.8 million.
  • The widest YoY moves for Income towards Parent Company: up 648.53% in 2022, down 1841.14% in 2022.
  • A 5-year view of Income towards Parent Company shows it stood at $110.0 million in 2022, then tumbled by 105.25% to -$5.8 million in 2023, then soared by 503.01% to $23.3 million in 2024, then plunged by 105.25% to -$1.2 million in 2025, then tumbled by 758.82% to -$10.5 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$10.5 million, -$1.2 million, and -$7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.51 Mn
Dec 31, 2025 -1.22 Mn
Sep 30, 2025 -7.74 Mn
Jun 30, 2025 -14.14 Mn
Mar 31, 2025 -15.70 Mn
Dec 31, 2024 23.30 Mn
Sep 30, 2024 -25.13 Mn
Jun 30, 2024 1.52 Mn
Mar 31, 2024 -9.95 Mn
Dec 31, 2023 -5.78 Mn
Sep 30, 2023 -19.31 Mn
Jun 30, 2023 -17.56 Mn
Mar 31, 2023 -16.46 Mn
Dec 31, 2022 110.02 Mn
Sep 30, 2022 -5.14 Mn
Jun 30, 2022 -69.96 Mn
Mar 31, 2022 -31.56 Mn
Dec 31, 2021 14.70 Mn
Sep 30, 2021 -13.15 Mn
Jun 30, 2021 7.81 Mn